Cargando…
Refined control of CRISPR-Cas9 gene editing in Clostridium sporogenes: the creation of recombinant strains for therapeutic applications
Despite considerable clinical success, the potential of cancer immunotherapy is restricted by a lack of tumour-targeting strategies. Treatment requires systemic delivery of cytokines or antibodies at high levels to achieve clinically effective doses at malignant sites. This is exacerbated by poor pe...
Autores principales: | Kubiak, Aleksandra M., Claessen, Luuk, Zhang, Yanchao, Khazaie, Khashayarsha, Bailey, Tom S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585264/ https://www.ncbi.nlm.nih.gov/pubmed/37869009 http://dx.doi.org/10.3389/fimmu.2023.1241632 |
Ejemplares similares
-
Streamlined assembly of cloning and genome editing vectors for genus Clostridium
por: Bailey, Tom S., et al.
Publicado: (2023) -
Efficient Secretion of Murine IL-2 From an Attenuated Strain of Clostridium sporogenes, a Novel Delivery Vehicle for Cancer Immunotherapy
por: Kubiak, Aleksandra M., et al.
Publicado: (2021) -
Endogenous CRISPR-Cas Systems in Group I Clostridium botulinum and Clostridium sporogenes Do Not Directly Target the Botulinum Neurotoxin Gene Cluster
por: Wentz, Travis G., et al.
Publicado: (2022) -
Clostridium sporogenes bacteremia in an immunocompetent patient
por: Abusnina, Waiel, et al.
Publicado: (2019) -
Bacteremia caused by Clostridium sporogenes in an oncological patient
por: Cobo, Fernando, et al.
Publicado: (2023)